Skip to main content

SENS

Stock
Health Care
Medical Devices

Performance overview

SENS Price
Price Chart

Forward-looking statistics

Beta
2.07
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Company info

SectorHealth Care
IndustryMedical Devices
Employees147
Market cap$217.7M

Fundamentals

Enterprise value$288.5M
Revenue$23.7M
Revenue per employee—
Profit margin2.37%
Debt to equity116.70

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$0.11
Dividend per share—
Revenue per share$0.04
Avg trading volume (30 day)$3M
Avg trading volume (10 day)$4M
Put-call ratio—

Macro factor sensitivity

Growth+5.4
Credit-15.1
Liquidity+2.3
Inflation+5.4
Commodities+0.4
Interest Rates-1.3

Valuation

Dividend yield0.00%
PEG Ratio-4.19
Price to sales17.18
P/E Ratio-4.19
Enterprise Value to Revenue12.18
Price to book9.31

Upcoming events

Next earnings dayMay 9, 2025
Next dividend day—
Ex. dividend day—

News

Here's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 Weeks

The heavy selling pressure might have exhausted for Senseonics (SENS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks Investment Research (June 18, 2025)
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga (March 29, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free